The databook is designed to serve as a comprehensive guide to navigating this
sector. The databook focuses on market statistics denoted in the form of
revenue and y-o-y growth and CAGR across the globe and regions. A detailed
competitive and opportunity analyses related to clinical trials market will
help companies and investors design strategic landscapes.
phase iii was the
largest segment with a revenue share of
53.34% in
2023.
Horizon Databook has segmented the Global clinical trials market based on phase i, phase ii, phase iii, phase iv covering the revenue growth of each sub-segment from 2018 to
2030.
- Global Clinical Trials Phase Outlook (Revenue, USD Million, 2018-2030)
- Phase I
- Phase II
- Phase III
- Phase IV
- Global Clinical Trials Study Design Outlook (Revenue, USD Million, 2018-2030)
- Interventional studies
- Observational studies
- Expanded access studies
- Global Clinical Trials Indication Outlook (Revenue, USD Million, 2018-2030)
- Autoimmune/Inflammation
- Rheumatoid arthritis
- Multiple sclerosis
- Osteoarthritis
- Irritable Bowel Syndrome (IBS)
- Others
- Pain management
- Oncology
- Blood cancer
- Solid tumors
- Other
- CNS conditions
- Epilepsy
- Parkinson's Disease (PD)
- Huntington's Disease
- Stroke
- Traumatic Brain Injury (TBI)
- Amyotrophic Lateral Sclerosis (ALS)
- Muscle regeneration
- Others
- Diabetes
- Obesity
- Cardiovascular
- Others
- Global Clinical Trials Service Type Outlook (Revenue, USD Million, 2018-2030)
- Protocol Designing
- Site Identification
- Patient Recruitment
- Laboratory Services
- Bioanalytical Testing Services
- Clinical Trial Data Management Services
- Others
- Global Clinical Trials Sponser Outlook (Revenue, USD Million, 2018-2030)
- Pharmaceutical & biopharmaceutical companies
- Medical device companies
- Others
Reasons to
subscribe to Global clinical trials market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of
Global clinical trials market databook
-
Our clientele includes a mix of clinical trials market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed
overview of
global-level
data and insights on the Global clinical trials market , including
forecasts for subscribers. This
global
databook contains high-level insights into
Global clinical trials market from
2018 to
2030, including revenue
numbers, major trends, and company profiles.